*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Wall Street stocks finished in the green on Thursday, as major indices attempted to claw back some of what had been lost over the last two days of heavy losses.
Stocks on the Continent ended the session little changed as investors chose to sit on their hands ahead of a barrage of earnings results from US tech giants Apple, Amazon and Facebook which were scheduled for release after the close of trading on Wall Street.
Aerospace and Defence was again the biggest drag in London markets, with Rolls Royce seeing profit-taking after the engineer's well received rights issue just the day before.
The focus at the end of the week will be firmly on the US technology sector as investors digest the results from three of the biggest corporate names globally, Apple, Amazon and Facebook.
London stocks closed just below the waterline on Thursday after a turbulent session, as investors weighed concerns about tightening Covid-19 restrictions across Europe, and cheered results from the likes of Lloyds, BT and Shell.
Precious and base metals exploration and development company Greatland Gold updated the market on Newcrest's drilling campaign at Greatland's Havieron deposit in the Paterson region of Western Australia on Thursday.
Nigeria-focussed oil and gas exploration and production company Lekoil has entered into a strategic alliance agreement with Namcor Exploration and Production through its subsidiary, Lekoil Namibia, it announced on Thursday.
Standard Life Aberdeen revealed on Thursday that chief executive Stephen Bird had purchased 500,000 ordinary shares in the FTSE 100-listed investment company.
Water Intelligence announced the signing and launch of another formal national contract between its American Leak Detection (ALD) subsidiary, and an unnamed “leading” insurance company in the United States on Thursday.
Trident Royalties announced on Thursday that all pre-conditions to the Lake Rebecca gold royalty acquisition had now been satisfied, with completion to occur automatically on admission of new shares.
Communication and radio frequency technology company MTI Wireless Edge announced on Thursday that the St Petersburg office of MTI Summit has secured a significant order for delivery in 2021 from a Russian customer.
Rare earth elements mining exploration company Altona Energy announced on Thursday that Leadway Group has been granted a three-year exploration licence for its tenement ‘EL00115’, known as the Nankoma Rare Earths Project.
Biopharmaceutical company Amryt Pharma announced positive results from its pivotal phase 23 ‘EASE’ trial of ‘Filsuvez’, or ‘Oleogel-S10’, previously ‘AP101’, on Thursday.
Biotechnology company Tiziana Life Sciences announced on Thursday that the capital reduction required for the demerger of StemPrintER Sciences, and to enable the ultimate allotment of Accustem Sciences shares to its shareholders, has been sanctioned by the court.
Wall Street stocks opened higher on Thursday as major indices attempted to claw back some of what had been lost over the last two days of heavy losses.
One of the front-runners in the global efforts to acquire a vaccine against Covid-19 said it was on track to report on the preliminary results of its clinical studies in November.
